IL-9 and Blimp-1 protect the transcriptional identity of group 2 innate lymphocytes in allergic asthma
Allergic asthma is driven by type 2 immune responses, including type 2 innate lymphoid cells (ILC2s). Although ILC2s are activated by the tissue alarmins interleukin (IL)-33 and IL-25, these signals do not intrinsically enforce type 2 identity and the mechanisms that maintain type 2 cytokine expression remain unclear. Here we show that allergen-induced IL-33 and IL-25 rapidly induce IL-9, which in turn upregulates the transcriptional repressor Blimp-1 in ILC2s. Blimp-1 sustains type 2 immunity by directly repressing type 1 inflammatory programs, including expression of interferon-γ and tumor necrosis factor. Deletion of Blimp-1 in ILC2s increased type 1 cytokine production and reduced IL-5 and IL-13 expression, eosinophil recruitment and mucus production in the lung. In contrast, IL-9 expression was enhanced in the absence of Blimp-1, leading to increased mast cell recruitment. Together, these findings identify Blimp-1 as a key regulator of ILC2 transcriptional fidelity that stabilizes type 2 inflammation while constraining divergent inflammatory programs during allergic responses.
Authors
- Anthony Marinov (ORCID: https://orcid.org/0000-0003-3876-747X)
- Aaron Yang (ORCID: https://orcid.org/0000-0003-3319-4916)
- Kun He (ORCID: https://orcid.org/0009-0006-5036-6889)
- Harshita Beeravolu
- Amanda C. Poholek (ORCID: https://orcid.org/0000-0002-5587-8940)
- Abbe Pannucci
- Shilpi Giri (ORCID: https://orcid.org/0000-0002-1861-9421)
- Anuradha Ray (ORCID: https://orcid.org/0000-0001-6844-8918)
- Daniella M. Schwartz (ORCID: https://orcid.org/0000-0002-1660-8438)
- Rachel A. Gottschalk (ORCID: https://orcid.org/0000-0002-5248-8816)
- Jeremy S. Tilstra (ORCID: https://orcid.org/0000-0003-0877-9971)
- Nicolas Bouladoux (ORCID: https://orcid.org/0000-0003-1593-671X)
- Anthony R. Cillo (ORCID: https://orcid.org/0000-0002-3213-3129)
- Arianna Creech
- Jinyi Zhang (ORCID: https://orcid.org/0000-0003-0606-4948)
- Yijia Chen (ORCID: https://orcid.org/0000-0001-7033-9593)
- Sagar L. Kale
- Yasmine Belkaid
- Yibo Zheng
Institutions
- National Institutes of Health (US)
- Institut Pasteur (FR)
- University of Pittsburgh (US)
- UPMC Hillman Cancer Center (US)
- National Institute of Allergy and Infectious Diseases (US)
- Tsinghua University (CN)
Publication Details
- Journal
- Nature Immunology
- Published
- 2026-04-24
- DOI
- https://doi.org/10.1038/s41590-026-02509-3
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Lung Association
- Tsinghua University
- National Institute of Allergy and Infectious Diseases